Cresilon, Inc. funding
Cresilon, Inc., a biotechnology company based in Brooklyn, NY, filed a Form D with the SEC on April 29, 2026 and reported $5M raised of a $25M offering. It filed 2 new offerings in this period, totaling $11.7M.
Amount raised$5M
Offering size$25M
Filed with the SECApril 29, 2026
First saleApril 24, 2026
IndustryBiotechnology
SecuritiesDebt, Options or warrants
LocationBrooklyn, NY
FoundedMore than 5 years ago
Entity typeCorporation
Investors so far21
Minimum investment$12K
Revenue rangeDecline to Disclose
View the original Form D on SEC EDGAR ↗ · All rounds filed Apr 29
All filings
| Filed | Raised | Offering | Securities |
|---|---|---|---|
| April 29, 2026 | $5M | $25M | Debt, Options or warrants |
| December 8, 2025 | $6.7M | $6.7M | Equity |
Other health care rounds in New York
Precision Neuroscience Corp$250M · Sep 28Other Health CareClick Therapeutics, Inc.$50M · Oct 1Other Health CareAmani Therapeutics, Inc.$35M · Oct 1Other Health CareAtmos Clinic, Inc.$6M · Oct 8Other Health CareCAD Therapeutics, Inc.$4M · Oct 2BiotechnologyPreciseDx, Inc.$3.7M · Oct 7Other Health CareHypercell Technologies Inc.$3M · Oct 14BiotechnologyAmorSui Inc.$2.7M · Sep 23Other Health Care